Moody’s: Viatris’ Pacira deal boosts acute pain presence
Moody’s said Viatris’ acquisition of Pacira Biosciences increases its presence in acute pain management, and that its ratings were not impacted.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.